跳至主要内容
临床试验/NCT05321368
NCT05321368招募中不适用

A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities

Johns Hopkins University6 个研究点 分布在 1 个国家目标入组 425 人开始时间: 2023年10月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
425
试验地点
6
主要终点
Blood Pressure Control as assessed by percentage of participants with controlled Blood Pressure

研究概览

简要总结

The LINKED- HEARTS Program is a multi-level project that intervenes at the practice level by linking home blood pressure monitoring (HBPM) with a telemonitoring platform (Sphygmo). The program incorporates team-based care by including community health workers (CHWs) and pharmacists to improve the outcomes of multiple chronic conditions (reduced blood pressure (BP), lower blood sugar, and improved kidney function). The LINKED-HEARTS Program will recruit a total of 600 adults with uncontrolled hypertension (BP ≥ 140/90 mm Hg) AND either type 2 diabetes or chronic kidney disease (CKD) across 16 community health centers or primary care practices serving high-risk adults. This cluster-randomized trial consists of two arms: (1) enhanced "usual care arm," wherein patients will be provided with Omron 10 series home BP monitors and will be managed by the patients' primary care clinicians as usual; and (2) the "intervention arm" which will integrate HBPM telemonitoring, a CHW intervention and provider-level interventions into the usual clinical care to improve BP control and provide support for self-management of chronic conditions. The study pharmacist will conduct telehealth, use the Sphygmo app and the Pharmacist Patient Care Process to collaborate with other providers to optimize pharmacologic therapy to improve hypertension outcomes and with payors to ensure consistent access to drug therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age as of date of data extraction,
  • Self-identify as non-Hispanic white, non-Hispanic Black/African American and/or Hispanic,
  • Diagnosis of Hypertension (HTN) defined by International Classification of Diseases, Tenth code (ICD-10 code) and elevated systolic blood pressure (SBP) measure (≥140 mm Hg) on their most recent clinic visit.
  • Diagnosis of diabetes or chronic kidney disease (both defined by ICD-10 code), in addition to HTN
  • Receives primary medical care at one of the participating health systems
  • Have a Maryland and D.C. home address

排除标准

  • Age <18 years
  • Diagnosis of end-stage renal disease (ESRD) treated with dialysis
  • Serious medical condition which either limits life expectancy or requires active management (e.g., cancer)
  • Cognitive impairment or other condition preventing participation in the intervention
  • Planning to leave the practice or move out of the geographic area in 24 months
  • No longer consider the practice site their location for primary care
  • Unwillingness to provide informed consent

结局指标

主要结局

Blood Pressure Control as assessed by percentage of participants with controlled Blood Pressure

时间窗: 12 months

Percent of patients with controlled Blood Pressure (\<140/90 mm Hg).

次要结局

  • Mean change in Estimated Glomerular Filtration Rate(Baseline and 12 months)
  • Change in Health-Related Quality of Life as assessed by the PROMIS 29(12 months and 24 months)
  • Percent with Hemoglobin A1c < 7.0(Baseline and 12 months)
  • Change in Systolic Blood Pressure(Baseline and 12 months)
  • Change in Diastolic blood pressure(Baseline and 12 months)
  • Mean change in Hemoglobin A1c(Baseline and 12 months)
  • Change in Body Mass Index (BMI)(Baseline and 12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

A Cardiometabolic Health Program Linked With... | 临床试验